These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9554941)

  • 1. Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat.
    Jiang N; Chopp M; Chahwala S
    Brain Res; 1998 Mar; 788(1-2):25-34. PubMed ID: 9554941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats.
    Jiang N; Moyle M; Soule HR; Rote WE; Chopp M
    Ann Neurol; 1995 Dec; 38(6):935-42. PubMed ID: 8526467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed treatment with nicotinamide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats.
    Mokudai T; Ayoub IA; Sakakibara Y; Lee EJ; Ogilvy CS; Maynard KI
    Stroke; 2000 Jul; 31(7):1679-85. PubMed ID: 10884473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischaemia in the rat.
    Mackay KB; Bailey SJ; King PD; Patel S; Hamilton TC; Campbell CA
    Neurodegeneration; 1996 Dec; 5(4):319-23. PubMed ID: 9117543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
    Tatlisumak T; Takano K; Meiler MR; Fisher M
    Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat.
    Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    Brain Res Bull; 2017 Oct; 135():62-68. PubMed ID: 28964774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion.
    Harukuni I; Bhardwaj A; Shaivitz AB; DeVries AC; London ED; Hurn PD; Traystman RJ; Kirsch JR; Faraci FM
    Stroke; 2000 Apr; 31(4):976-82. PubMed ID: 10754008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
    Sydserff SG; Borelli AR; Green AR; Cross AJ
    Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury.
    Bochelen D; Rudin M; Sauter A
    J Pharmacol Exp Ther; 1999 Feb; 288(2):653-9. PubMed ID: 9918571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxyresveratrol (trans-2,3',4,5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia.
    Andrabi SA; Spina MG; Lorenz P; Ebmeyer U; Wolf G; Horn TF
    Brain Res; 2004 Aug; 1017(1-2):98-107. PubMed ID: 15261105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
    Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats.
    Nito C; Kamiya T; Ueda M; Arii T; Katayama Y
    Brain Res; 2004 May; 1008(2):179-85. PubMed ID: 15145754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aminoguanidine on post-ischemic damage in rodent model of stroke.
    Vakili A; Zahedi-Khorasani M
    Pak J Pharm Sci; 2008 Jan; 21(1):24-8. PubMed ID: 18166515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats.
    Markgraf CG; Velayo NL; Johnson MP; McCarty DR; Medhi S; Koehl JR; Chmielewski PA; Linnik MD
    Stroke; 1998 Jan; 29(1):152-8. PubMed ID: 9445345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
    Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
    Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal dependent neuroprotection with propentofylline (HWA 285) in a temporary focal ischemia model.
    Johnson MP; McCarty DR; Chmielewski PA
    Eur J Pharmacol; 1998 Apr; 346(2-3):151-7. PubMed ID: 9652354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbaric oxygen preconditioning induces neuroprotection against ischemia in transient not permanent middle cerebral artery occlusion rat model.
    Xiong L; Zhu Z; Dong H; Hu W; Hou L; Chen S
    Chin Med J (Engl); 2000 Sep; 113(9):836-9. PubMed ID: 11776082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
    Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postischemic treatment (2-4 h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2 h) focal cerebral ischemia in the rat.
    Zhang ZG; Chopp M; Tang WX; Jiang N; Zhang RL
    Brain Res; 1995 Nov; 698(1-2):79-85. PubMed ID: 8581506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.